anagrelide

Generic: anagrelide

Labeler: torrent pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name anagrelide
Generic Name anagrelide
Labeler torrent pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

anagrelide hydrochloride anhydrous 1 mg/1

Manufacturer
Torrent Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 13668-462
Product ID 13668-462_a049d02a-22e1-4ea2-8c05-50b50cef4362
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209151
Listing Expiration 2026-12-31
Marketing Start 2017-06-30

Pharmacologic Class

Classes
decreased platelet production [pe] phosphodiesterase 3 inhibitors [moa] platelet-reducing agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13668462
Hyphenated Format 13668-462

Supplemental Identifiers

RxCUI
597850 597852
UPC
0313668453300 0313668462302
UNII
VNS4435G39

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anagrelide (source: ndc)
Generic Name anagrelide (source: ndc)
Application Number ANDA209151 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (13668-462-01)
  • 30 CAPSULE in 1 BOTTLE (13668-462-30)
source: ndc

Packages (2)

13668-462-01 100 CAPSULE in 1 BOTTLE (13668-462-01) 13668-462-30 30 CAPSULE in 1 BOTTLE (13668-462-30)

Ingredients (1)

anagrelide hydrochloride anhydrous (1 mg/1)

Linked Drug Pages (1)

anagrelide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a049d02a-22e1-4ea2-8c05-50b50cef4362", "openfda": {"upc": ["0313668453300", "0313668462302"], "unii": ["VNS4435G39"], "rxcui": ["597850", "597852"], "spl_set_id": ["875cc32a-219c-4b6b-802a-98a47cbc9a78"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (13668-462-01)", "package_ndc": "13668-462-01", "marketing_start_date": "20170630"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (13668-462-30)", "package_ndc": "13668-462-30", "marketing_start_date": "20170630"}], "brand_name": "anagrelide", "product_id": "13668-462_a049d02a-22e1-4ea2-8c05-50b50cef4362", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "13668-462", "generic_name": "anagrelide", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "anagrelide", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS", "strength": "1 mg/1"}], "application_number": "ANDA209151", "marketing_category": "ANDA", "marketing_start_date": "20170630", "listing_expiration_date": "20261231"}